Clinical Trial Update: Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) [Phase 1, Phase 2]

View source ↗

Summary

Early-phase study evaluating the safety and preliminary efficacy of combining ibrutinib with pembrolizumab in chronic lymphocytic leukemia or mantle cell lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma

Drugs mentioned

• IMBRUVICA (IBRUTINIB)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Joshua Brody | Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING